Biogen Idec, Pfizer, Bristol-Myers and Celgene are among companies awaiting US approval of key treatments.
Neither party seems to understand the consequences of what Congress does to American businesses.
Analysts expect pomalidomide will win US approval in February, adding a potential blockbuster treatment to the biotech's drug lineup.
Skechers is upgraded to 'positive,' and Yum Brands is initiated with an 'outperform.'
Clinical trials, drug launches and FDA approval decisions fill the calendar for these companies at the start of the new year.
Groupon is downgraded to 'equal weight,' while Isis Pharmaceuticals is upgraded to 'outperform.'
The company's Abraxane delays tumor growth in patients with advanced melanoma.
The country is reportedly preparing to ask for aid. US home prices rise. GM and Chrysler post sales gains, but Ford's sales are flat. MetroPCS soars on a deal rumor. PetSmart will replace Sunoco in the S&P 500.
VIDEO ON MSN MONEY
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
TOP STOCKS
The auto parts giant beats Wall Street expectations, while continuing to expand its stores in the U.S. and Mexico.
MARKET DISPATCHES
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
FRUGAL COOL
Starting Monday, this site is joining forces with MSN Money Smart Spending. Here's why.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
SMART SPENDING
Hurricane season is coming. But storms can happen at any time. Here are six smart things to do to get your home ready before the storm hits.
SMART TAXES
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.
